New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
05:47 EDTSTJSt. Jude Medical announces preliminary results from EnligHTN III study
St. Jude Medical announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. Results from the EnligHTN I, II and III trials presented during EuroPCR add to the growing body of clinical evidence supporting the benefits of EnligHTN renal denervation technologies.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 1, 2014
15:59 EDTSTJSt. Jude Medical announces new Fractional Flow Reserve trial
Subscribe for More Information
August 31, 2014
13:53 EDTSTJSt. Jude Medical Quartet quadripolar lead performed better than bipolar leads
Subscribe for More Information
August 28, 2014
17:42 EDTSTJJ&J begins sales process for its medical device unit Cordis, WSJ says
Subscribe for More Information
August 26, 2014
16:29 EDTSTJSt. Jude Medical resolves FDA warning letter for Plano facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use